{"entity":{"id":"regional-nodal-irradiation","kind":"term","name":"Regional nodal irradiation in breast cancer","aka":["regional nodal irradiation","RNI"],"tldr":"Regional nodal irradiation treats selected lymph-node regions. The exact fields, pretreatment findings and response after earlier therapy determine the clinical question.","summary":"Fields can include axillary, supraclavicular and internal mammary node regions, depending on the plan. This is distinct from breast or chest-wall irradiation, though they can be combined. After neoadjuvant treatment, ypN0 is a pathological nodal classification. Retain the sampled nodes and modifiers, including isolated-cell categories, rather than interpreting it as proof of absolute cellular absence or complete response in the breast.\n\nB-51 studied biopsy-proven cT1 to T3 N1 M0 disease that became ypN0. Its primary recurrence-interval comparison was not statistically significant at median follow-up 59.5 months; this is not proof of zero effect in all settings. After lumpectomy both groups received whole-breast radiation. After mastectomy the contrast included chest-wall plus nodal radiation versus none.\n\nA011202 instead studies residual positive sentinel nodes after neoadjuvant chemotherapy. Its registry describes dissection plus nodal radiation versus axillary and nodal radiation without dissection; both strategies include radiation. Do not transfer an omission conclusion between these different populations and contrasts. Organ exposure, lymphoedema and other harms remain part of the assessment.","asOf":"2026-11-09","links":[{"label":"B-51 primary report","url":"https://pubmed.ncbi.nlm.nih.gov/40466065/"},{"label":"B-51 surgery-specific registry arms","url":"https://clinicaltrials.gov/study/NCT01872975"},{"label":"A011202 residual-node-positive registry arms","url":"https://clinicaltrials.gov/study/NCT01901094"},{"label":"NCI: radiation for breast cancer","url":"https://www.cancer.gov/types/breast/treatment/radiation"}],"tags":["education-audit","local-treatment"],"related":["lymph-node-status","sentinel-node","radiotherapy","completion-surgery","mastectomy","lumpectomy"],"cancers":["breast-cancer","tnbc"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["nsabp-b51","alliance-a011202"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"category":"Clinic basics"},"route":"/terms/regional-nodal-irradiation/","neighbours":{"term":[{"id":"completion-surgery","kind":"term","name":"Completion surgery","route":"/terms/completion-surgery/"},{"id":"lumpectomy","kind":"term","name":"Lumpectomy (breast-conserving surgery)","route":"/terms/lumpectomy/"},{"id":"lymph-node-status","kind":"term","name":"Lymph node status (node-positive / node-negative)","route":"/terms/lymph-node-status/"},{"id":"mastectomy","kind":"term","name":"Mastectomy","route":"/terms/mastectomy/"},{"id":"radiotherapy","kind":"term","name":"Radiotherapy","route":"/terms/radiotherapy/"}],"technology":[{"id":"sentinel-node","kind":"technology","name":"Sentinel lymph node biopsy","route":"/technologies/sentinel-node/"}],"cancer":[{"id":"breast-cancer","kind":"cancer","name":"Breast cancer (all types)","route":"/cancers/breast-cancer/"},{"id":"tnbc","kind":"cancer","name":"Triple-negative breast cancer (TNBC)","route":"/cancers/tnbc/"}],"trial":[{"id":"alliance-a011202","kind":"trial","name":"Alliance A011202: axillary treatment after residual positive sentinel nodes","route":"/trials/alliance-a011202/"},{"id":"nsabp-b51","kind":"trial","name":"NSABP B-51 / RTOG 1304","route":"/trials/nsabp-b51/"}]}}